Loci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations

Rita P. Middelberg, Beben Benyamin, Marleen H.M. de Moor, Nicole M. Warrington, Scott Gordon, Anjali K. Henders, Sarah E. Medland, Dale R. Nyholt, Eco J.C. de Geus, Jouke J. Hottenga, Gonneke Willemsen, Lawrence J. Beilin, Trevor A. Mori, Margaret J. Wright, Andrew C. Heath, Pamela A.F. Madden, Dorret I. Boomsma, Craig E. Pennell, Grant W. Montgomery, Nicholas G. MartinJohn B. Whitfield

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

Serum gamma-glutamyl transferase (GGT) activity is a marker of liver disease which is also prospectively associated with the risk of all-cause mortality, cardiovascular disease, type 2 diabetes and cancers. We have discovered novel loci affecting GGT in a genome-wide association study (rs1497406 in an intergenic region of chromosome 1, P = 3.9 × 10 -8; rs944002 in C14orf73 on chromosome 14, P = 4.7 × 10 -13; rs340005 in RORA on chromosome 15, P = 2.4 × 10 -8), and a highly significant heterogeneity between adult and adolescent results at the GGT1 locus on chromosome 22 (maximum P HET = 5.6 × 10 -12 at rs6519520). Pathway analysis of significant and suggestive single-nucleotide polymorphism associations showed significant overlap between genes affecting GGT and those affecting common metabolic and inflammatory diseases, and identified the hepatic nuclear factor (HNF) family as controllers of a network of genes affecting GGT. Our results reinforce the disease associations of GGT and demonstrate that control by the GGT1 locus varies with age.

Original languageEnglish
Article numberddr478
Pages (from-to)446-455
Number of pages10
JournalHuman molecular genetics
Volume21
Issue number2
DOIs
Publication statusPublished or Issued - Jan 2012
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this